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Variation in the serum creatinine assay calibration: A practical
application to glomerular filtration rate estimation.
Background. Variation among clinical laboratories in calibra-
tion of serum creatinine assays is a source of error in glomeru-
lar filtration rate (GFR) estimation equations. We evaluated
impact of this variation on GFR estimates.
Methods. Errors in GFR estimates were computed based on
the range of calibration differences from the 1994 College of
American Pathologists (CAP) survey using the Modification of
Diet in Renal Disease (MDRD) Study GFR equation.
Results. Mean (95% CI) calibration difference observed in
the CAP survey was +0.14 mg/dL (+12.4 lmol/L) [−0.09, +0.37
mg/dL (−7.96, +32.71 lmol/L)]. Errors in GFR estimates using
uncalibrated serum creatinine values were lower in individu-
als with lower estimated GFR. For GFR of 60 mL/min/1.73m2,
the mean calibration difference in the CAP survey was asso-
ciated with errors in GFR estimation between −5.5 to −8.1
mL/min/1.73 m2 (−9.1 to −13.5%) depending on race and sex.
The 95% confidence interval for the calibration difference was
associated with a maximal range of error in GFR estimates from
+4.6 to −18.1 mL/min/1.73 m2 (+7.6 to −30.2%). Errors of this
magnitude at an estimated GFR of 60 mL/min/1.73 m2 are not
likely to be of clinical significance. However, errors at higher
levels of estimated GFR would be greater, making GFR esti-
mates in this range unreliable.
Conclusion. Recalibration of serum creatinine assays to the
MDRD Study clinical laboratory would improve accuracy of
GFR estimation using the MDRD Study equation, but is
not practical for all clinical laboratories. As an interim so-
lution, clinical laboratories could report GFR estimates <60
mL/min/1.73m2 without recalibration with an acceptable accu-
racy.
Chronic kidney disease (CKD) is a major worldwide
public health problem. Glomerular filtration rate (GFR)
is the best overall index of kidney function to diag-
nose, stage, and appropriately treat CKD. Due to well-
recognized limitations of serum creatinine as an index of
Key words: serum creatinine, creatinine assay, calibration, glomerular
filtration rate, chronic kidney disease.
Received for publication January 15, 2005
and in revised form March 18, 2005
Accepted for publication May 10, 2005
C© 2005 by the International Society of Nephrology
kidney function, international organizations now recom-
mend use of GFR estimating equations based on serum
creatinine and other demographic and clinical variables
to assess kidney function, and that clinical laboratories
report estimated GFR whenever serum creatinine is or-
dered [1–4]. Due to substantial interlaboratory variation
in creatinine assays, creatinine-based estimating equa-
tions require calibration of the serum creatinine to the
laboratory that developed the equation. Failure to do so
can introduce a systematic bias in the estimated GFR [5–
7]; however, a widespread calibration effort of all clinical
laboratories to one research laboratory is not feasible.
We determined the impact of calibration on GFR es-
timation using the range of calibration differences ob-
served in the 1994 College of American Pathologists
(CAP) survey of clinical laboratories [8] and the GFR es-
timating equation derived from the Modification of Diet
in Renal Disease (MDRD) Study equation [9; abstract;
Levey AS, et al, and MDRD Study Group. J Am Soc
Nephrol 11:155A, 2000 (abstract A0828)].
The study design was a secondary analysis of published
data. A 1994 survey by the College of American Patholo-
gists (CAP) [8] compared serum creatinine assay methods
of clinical laboratories. In this survey, fresh frozen sam-
ples with a serum creatinine concentration of 0.86 mg/dL
(76 lmol/L) were sent to 554 clinical laboratories for as-
say. The results showed that the mean bias and standard
error between clinical laboratories and the reference lab-
oratory was +16% and 0.58%, respectively.
From the mean bias and standard error, we computed
the mean and 95% confidence interval (CI) for the cal-
ibration differences between laboratories. GFR was es-
timated using the MDRD Study equation for black and
nonblack 60-year-old individuals of both sexes, without
calibration and across the observed 95% CI for calibra-
tion differences. The 4-variable MDRD Study equation
is GFR = 186.3 × (serum creatinine−1.154) × (age−0.203)
× 1.212 (if African American) × 0.742 (if female), where
serum creatinine is measured in mg/dL, age in years, and
GFR is expressed in mL/min/1.73m2. Age of 60 years was
selected because prevalence of CKD is higher in older
individuals [6]. Serum creatinine assay for the MDRD
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Table 1. Errors in GFR estimates due to calibration differences in a Hypothetical 60-year-old individual with an estimated GFR of 60
mL/min/1.73m2
Absolute and percent error in Range of absolute and percent error in
GFR estimate for mean GFR estimates for 95% confidence
calibration difference interval for calibration differences
60-year-old individual (+0.14 mg/dL) (−0.09, +0.37 mg/dL)
mL/min/1.73m2 % mL/min/1.73m2 %
Black male −5.5 −9.1 +4.6 to −13.4 +7.6 to −21.9
White male −6.6 −11.0 +5.1 to −15.1 +8.5 to −25.2
Black female −6.9 −11.5 +6.1 to −18.1 +10.1 to −26.7
White female −8.1 −13.5 +7.1 to −18.1 +11.9 to −30.2
GFR estimates computed using MDRD Study equation. Calibration differences observed in CAP survey (see text). Note: to convert serum creatinine in mg/dL to
lmol/L, multiply by 88.4.
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Figure 1. Estimated GFR with and without creatinine calibration for a 60-year-old black male. Lines represent estimated GFR values with and
without calibration of serum creatinine assay over the 95% confidence interval for calibration differences (factors) observed from the CAP survey
for a 60-year-old black male. Calibration factor of zero indicates no difference between laboratories in serum creatinine assay. For estimated GFR
<60 mL/min/1.73m2 a mean calibration difference of 0.14 mg/dL is associated with an error in GFR estimates of −9.1%. The upper and lower
limits of the 95% confidence intervals are −0.09 mg/dL and +0.37 mg/dL, respectively. The error in GFR estimates over this range is from +7.6%
to −21.9%. ∗To convert serum creatinine in mg/dL to lmol/L, multiply by 88.4.
Study was performed at the Cleveland Clinic NIH Core
Biochemistry Laboratory at the Cleveland Clinic Foun-
dation, using the Beckman Rate Jaffe`/CX3 Synchron as-
say based on the kinetic alkaline picrate reaction [10].
The mean calibration difference between the clinical
laboratories and the reference laboratory in the CAP
survey was +0.14 mg/dL (12.4 lmol/L). The 95% confi-
dence interval for calibration difference was −0.09, +0.37
mg/dL (−7.96, +32.71 lmol/L). Table 1 shows errors in
GFR estimates due to calibration differences observed
in the CAP survey for 60-year-old individuals with es-
timated GFR of 60 mL/min/1.73m2. At the mean cali-
bration difference, errors in GFR estimates ranged from
−5.5 to −8.1 mL/min/1.73m2 (−9.1% to −13.5%), de-
pending on race and sex. Errors in GFR estimates across
the 95% CI for calibration differences ranged from +4.6
to −18.1 mL/min/1.73m2 (+7.6% to −30.2%). Errors of
this magnitude at an estimated GFR of 60 mL/min/1.73m2
are not likely to be of clinical significance. However, er-
rors at higher levels of estimated GFR would be higher,
making GFR estimates unreliable.
Figure 1 demonstrates that the impact of calibration is
substantially greater at high levels of GFR. For a black
60-year-old man, the absolute errors in GFR estimates
for the mean calibration difference would be 1.6, 5.5, and
11.6 mL/min/1.73m2, corresponding to percent errors of
5.4%, 9.1%, and 12.8%, respectively, at GFR of 30, 60,
and 90 mL/min/1.73m2.
Serum creatinine assays vary systemically due to pos-
itive interference by proteins and other substances in
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normal serum, known as “noncreatinine chromogens.”
These substances are not retained in CKD, thus making
differences from calibration relatively greater at lower
serum creatinine levels. Failure to recalibrate the serum
creatinine assay to the laboratory in which the equation is
developed can lead to errors in GFR estimates, especially
at higher GFR ranges (lower serum creatinine).
Our results showed that when GFR estimated from cal-
ibrated serum creatinine is 60 mL/min/1.73m2, GFR esti-
mated without calibration may range from approximately
42 to 65 mL/min/1.73m2. We acknowledge that this range
includes the threshold level for the definition of CKD;
however, we believe that errors of this magnitude are not
likely to be of clinical significance if clinicians consider
GFR estimates in the context of the patient’s clinical fea-
tures. For example, in the absence of markers of kidney
damage (such as persistent proteinuria), risk factors for
CKD (such as diabetes or hypertension), and complica-
tions of CKD (such as anemia), it would be difficult to
determine whether a patient with estimated GFR in this
range truly has CKD.
We recommend that in the absence of calibration, clin-
ical laboratories report a specific value for GFR esti-
mates only when the estimated GFR is less than 60
mL/min/1.73m2 and as “≥60 mL/min/1.73m2” for higher
values. This is a practical proposal and is consistent
with current guidelines. First, the NKF-K/DOQI prac-
tice guidelines on CKD define individuals with GFR <60
mL/min/1.73m2 for ≥3 months as CKD stage 3 (moder-
ately decreased GFR) [2]. Individuals with higher GFR
are defined as having CKD only if there is a marker of
kidney damage. Second, complications CKD, such as car-
diovascular disease (CVD), anemia, malnutrition, bone
disease, and decreased quality of life generally occur
when GFR <60 mL/min/1.73m2 [11, 12]. Complications
of CKD and increased risk of CVD that occur at higher
GFR levels are more likely related to proteinuria rather
than GFR level. Third, studies have suggested referral
to nephrologists may improve outcomes, particularly in
patients about to initiate kidney replacement therapy
[13, 14]. Recent guidelines suggest nephrology referral
at GFR <30 mL/min/1.73m2 [2]. Error at estimated GFR
levels of 30 mL/min/1.73m2 without calibration is min-
imal, enabling use of these estimates for management.
Therefore, detection of GFR below this level can be fa-
cilitated by reporting GFR estimates, even without cali-
bration.
Differences in creatinine calibration are not the only
sources of error in GFR estimation. While GFR estimat-
ing equations provide significant benefit over serum cre-
atinine alone for kidney function assessment [15], they
do not account for factors affecting the generation, se-
cretion, and extrarenal elimination of creatinine, nor do
they account for random variations in GFR and serum
creatinine measurements. The relative contributions of
calibration differences and these other sources of error
are unknown. However, studies evaluating the perfor-
mance of MDRD Study equation using calibrated serum
creatinine assay [16, 17] demonstrated substantially less
bias than studies performed without calibration [18, 19,
20], suggesting calibration may be a major reason for poor
performance of the MDRD Study equation at higher lev-
els of GFR.
Note that use of equations other than MDRD Study
equation does not eliminate the errors introduced by dif-
ferences in calibration. Indeed, calibration is relevant for
all estimating equations, but is only possible for reference
laboratories that can trace their current assay to the assay
used for the development of the estimation equation.
The main limitation of our analysis is that the error in
GFR estimation due to calibration is simulated based on
CAP survey data, rather than directly observed in a study
population. However, our analysis provides a wide range
of calibration differences observed in the United States.
CONCLUSION
Recalibration of the serum creatinine assay to the labo-
ratory where the equation was developed is necessary for
accurate estimates of GFR, particularly at higher levels of
GFR. Undertaking a widespread calibration effort of all
clinical laboratories to the MDRD Study clinical labora-
tory is not feasible, nor is it practical. Until a program for
creatinine standardization is developed, we propose that
clinical laboratories could report GFR estimates below
60 mL/min/1.73m2 without calibration with an acceptable
accuracy for the most individuals.
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